CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to discover a specific inhibitor for the ATIC enzyme involved in cancer metabolism. By developing new peptide-like compounds, researchers will assess their effectiveness in cancer cell lines, contributing to better diagnosis and treatment options.
According to the WHO, in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths.
The proposed project fits perfectly into the Europe's Beating Cancer Plan, in particular the point ""Diagnosis and treatment and quality of life of cancer patients"".This project combines the expertise of scientists and academic centres from five different countries in three continents who are applying their knowledge at the frontiers of biology, chemistry, bioinformatics, biophysics and me…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Armenia, Yerevan
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Australia, Melbourne
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United States, Conway
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
